S-3323-119
Committee on Health, Education, Labor, and Pensions. Hearings held.
Sponsored by John Hickenlooper (D-CO)
What it does
This bill would write the Advisory Committee on Immunization Practices (ACIP) into federal statute, setting requirements for its membership (15-19 members recommended by the Comptroller General, plus ex-officio agency members), meeting frequency, transparency, and evidence standards for vaccine recommendations. It would require CDC's Director to adopt ACIP recommendations unless evidence-based reasons for rejection are published within 48 hours, and would apply similar evidence standards to changes in the Vaccine Injury Compensation Table. It authorizes $2.8 million per year for fiscal years 2026-2029 to fund committee operations.
Who benefits
Vaccine manufacturers and public health advocates who benefit from a stable, evidence-based, and transparent recommendation process; parents and patients who rely on ACIP recommendations for insurance coverage decisions (via section 2713) and the Vaccines for Children Program; ACIP members and affiliated professional and medical associations named as stakeholder liaisons (e.g., American Academy of Pediatrics, American Medical Association); Congress, which gains oversight visibility through mandatory 48-hour notifications when officials deviate from committee recommendations.
Who is hurt
The HHS Secretary and CDC Director, whose discretion to override or ignore ACIP recommendations would be constrained by statutory adoption and disclosure requirements; officials who might otherwise act quickly during emergencies without triggering formal evidence-based review and reporting; taxpayers, who would fund the $2.8 million annual authorization; possibly future administrations seeking to restructure or bypass the committee without going through Congress, since its structure would now require statutory amendment rather than internal HHS policy change.
Supporters argue
Supporters argue that codifying ACIP's structure, evidence standards, and transparency requirements would protect the vaccine recommendation process from being altered or dismantled by political appointees without congressional input, ensuring recommendations stay grounded in "the preponderance of the best available, peer-reviewed scientific evidence." They contend that requiring public disclosure and 48-hour congressional notification when officials deviate from committee advice increases accountability and helps preserve public trust in vaccine policy, particularly following recent controversies over HHS leadership changes affecting immunization guidance.
Opponents argue
Opponents argue that locking ACIP's membership criteria, procedures, and evidence-review requirements into statute would reduce the executive branch's flexibility to respond quickly to new scientific evidence or public health emergencies, since any structural change would require new legislation rather than administrative action. They contend that mandating deference to an advisory committee's recommendations, absent detailed published rebuttals, could slow decision-making during fast-moving outbreaks and shifts too much substantive authority to an unelected body rather than accountable political officials.
Constitutional context
This bill implicates the Take Care Clause and separation-of-powers principles governing how much statutory constraint Congress may place on executive discretion over public health decisions; it does not raise a Commerce Clause or taxing-power question like the ACA cases, since it does not compel private conduct. No landmark Supreme Court case directly governs the codification of an advisory committee's procedural authority, though general administrative law principles regarding delegation and executive discretion are relevant.
Checks and balances
Congress would gain durable oversight authority over vaccine policy by writing ACIP's structure and evidence standards into statute and requiring rapid notification when executive officials deviate from its recommendations, constraining the HHS Secretary's and CDC Director's discretion, which had previously been governed only by internal agency policy.
Historical precedent
ACIP has operated under HHS regulations and the Federal Advisory Committee Act since 1964 without prior statutory codification, making this the first attempt to establish its structure and procedures directly in law.